Conference Reports for NATAP
IDSA/IDWeek
2015, October 7-11
San Diego
Back
 
C-EDGE: INTEGRATED ANALYSIS FROM THE PHASE 2/3 STUDIES of ELBASVIR / GRAZOPREVIR in HIV PATIENTS WITH HCV/HIV
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA